XGN

ExagenA

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-06-11

View Chart

RSI (14)

55.6

Neutral

MACD Hist

-0.09

Bearish

ATR (14)

0.43

Normal

Vol Z (20)

-1.10

Normal

RET 20D

+16.4%

Positive

Dist 52W High

-62.5%

Below High

Technical chart

1 Year

Candles, moving averages, and volume using the current RankAlpha theme.

As of 2026-06-11

Price

SMA 20

SMA 50

SMA 200

Trend readout

Technical readout

Trend

Mixed trend (SMAs not aligned)

Momentum

Positive momentum · 20D +16.4% · 60D +48.3%

RSI / MACD

RSI 55.6 (Neutral) · MACD hist -0.09

Volatility

Volatility muted (Z -1.10)

SMA20

4.39

SMA50

3.58

SMA200

6.22

EMA12

4.42

EMA26

4.17

BB Upper

5.40

BB Mid

4.39

BB Lower

3.38

RET 5D

+4.4%

RET 20D

+16.4%

RET 60D

+48.3%

RET 120D

-30.8%

As of 2026-06-11 • Updated nightlySource: Internal modelMethodology